Sandra has over 20 years’ experience with professional medical societies and patient organizations specializing in oncology and rare disease. She understands the importance of bringing together all stakeholders to facilitate innovative solutions that improve patient care and outcomes. Sandra is recognized for award-winning awareness campaigns and her work on projects such as the Institute for Clinical Immuno-Oncology. Sandra has served in leadership roles with Association of Community Cancer Centers, MJH Life Sciences (CURE, Targeted Oncology), American Urological Association, and is a founding board member of the GI Cancers Alliance. Her consultative experience includes projects in head and neck cancer, lung cancer, and hematology.